Jianhua Nie
Harbin, 150081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Electroacupuncture combined with fruquintinib and sintilimab in microsatellite-stable metastatic colorectal cancer: A phase II study.
Journal: Cancer letters
Published: November 18, 2025
An etiology-stratified single-cell atlas identifies FABP4 as a prognostic marker for MASLD-related HCC.
Journal: Journal of hepatology
Published: December 17, 2024
PD-L1 inhibitor plus gemcitabine and cisplatin therapy followed by conversion surgery for initially unresectable advanced gallbladder cancer.
Journal: BMJ case reports
Published: December 20, 2023
The present roles and future perspectives of Interleukin-6 in biliary tract cancer.
Journal: Cytokine
Published: March 27, 2023
SHR6390 Combined with Cabozantinib Inhibits Tumor Progression in the Hepatocellular Carcinoma Mouse Model.
Journal: Current gene therapy
Published: March 18, 2022
Response Evaluation and Survival Prediction Following PD-1 Inhibitor in Patients With Advanced Hepatocellular Carcinoma: Comparison of the RECIST 1.1, iRECIST, and mRECIST Criteria.
Journal: Frontiers in oncology
Published: September 16, 2021
A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer.
Journal: Frontiers in oncology
Published: January 15, 2021
The status and progress of first-line treatment against Helicobacter pylori infection: a review.
Journal: Therapeutic advances in gastroenterology
Published: July 15, 2020
Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma.
Journal: Cancer letters
Published: August 12, 2018
Last Updated: 09/26/2026